1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Ascites Hepatic: new trials by email Literature Review of Ascites Hepatic trials Research Report on Ascites Hepatic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome Ambrisentan, Terlipressin - Hepatorenal Syndrome, Liver Cirrhosis | Phase 2 | Active not recruiting | Noorik Biopharmaceuticals AG | 54 | 2024-04-17 | 2026-04-13 |
Acute Kidney Injury (1) · Hepatorenal Syndrome (1) · Liver Cirrhosis (1)
Digestive System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Fibrosis (1) · Kidney Diseases (1) · Liver Diseases (1) · Male Urogenital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Terlipressin (1) · ambrisentan (1)
Noorik Biopharmaceuticals AG (1)
India (1)
Iker Navarro, MD (1)